Navigation Links
Albemarle Corporation's First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET
Date:4/7/2008

RICHMOND, Va., April 7, 2008 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB) will hold its quarterly conference call to discuss first quarter results on Tuesday, April 22, 2008, at 9:00am ET.

This call is being webcast by Thomson/CCBN and can be accessed at Albemarle Corporation's Web site at http://www.albemarle.com in the Investor Information section.

To listen to this conference, please call the following:

Dial In # 800-591-6942

International Dial In # 617-614-4909

Passcode 21020519

A replay of this call will be available beginning at 11:00AM ET

April 22, 2008 and will play until April 29, 2008 at the following

number:

Dial In # 888-286-8010

International Dial In # 617-801-6888

Passcode 74513981

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.earnings.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com).

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading producer of specialty chemicals for consumer electronics; transportation and industrial products; pharmaceuticals; agricultural products; construction and packaging materials. The company's three business segments, Polymer Additives, Catalysts and Fine Chemicals (which includes custom manufacturing services for the life sciences market) serve customers in nearly 100 countries, generating annual revenue of approximately $2.4 billion. Learn more about Albemarle at http://www.albemarle.com .


'/>"/>
SOURCE Albemarle Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Albemarle Raises Prices of Specialty Aluminas
2. Albemarle to Raise Prices of Dibromomethane
3. Albemarle Reports Third Quarter 2007 Results
4. Albemarle to Increase Price of Ibuprofen
5. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
6. GetWellNetwork Kicks Off GetConnected2008, First Annual Users Conference
7. Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008
8. Stiefel Laboratories Appoints First Chief Scientific Officer
9. Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call
10. Exponent to Report First Quarter Fiscal 2008 Results
11. NTMir Announces First International Research Grant for Genome Sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... ... questioned the use of the HyProCure sinus tarsi implant. ( http://www.cbc.ca/news/canada/ottawa/banned-quebec-dentist-pierre-dupont-working-as-chiropodist-in-ottawa-1.3515494 ) ... is a minimally invasive procedure performed, when indicated, to correct the partial ...
(Date:4/29/2016)... ... ... In an article published April 16th on the New York ... injections, which she underwent in order to feel more at home at this year’s ... article explains that Ms. Mirmelli’s situation is not unique; many plastic surgeons say they’ve ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... , ... Coast Dental Fort Stewart is celebrating its grand opening with an ... Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be refreshments, giveaways, ... have the opportunity to meet general dentists Thomas Richards, DDS, and Josh Faulk, DMD, ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
Breaking Medicine Technology: